What is the current Price Target for the Cansino Biologics Inc-h stock?

The average Cansino Biologics Inc-h target price is CN¥68.06. This is 0.02% higher than the current stock price. The highest price target is 2.96%, the lowest is -0.96%. 3 Analysts have issued a price target Cansino Biologics Inc-h 2027 .

How high will the Cansino Biologics Inc-h stock rise?

No reliable answer can be given as to how high the Cansino Biologics Inc-h stock will rise. The performance of stocks, including the Cansino Biologics Inc-h stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Cansino Biologics Inc-h stock today?

The performance of Cansino Biologics Inc-h stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Cansino Biologics Inc-h stock fall?

The decline in Cansino Biologics Inc-h stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Cansino Biologics Inc-h Forecast, price target & analysts

CN¥68.05

3.03%

Shanghai, Sep 18, 03:00 pm CST. Closed.

ISIN

CNE100003F01

Symbol

688185

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts Ownership Strategies

Cansino Biologics Inc-h Target price 2026 - Analyst rating & recommendation

Cansino Biologics Inc-h Classifications & Recommendation

Buy

86%

Hold

14%

Cansino Biologics Inc-h Price Target

Target Price	CN¥68.06
Price	CN¥68.05
Potential	0.02% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target Cansino Biologics Inc-h 2027 . The average Cansino Biologics Inc-h target price is CN¥68.06. This is 0.02% register free of charge higher than the current stock price. The highest price target is CN¥70.07 2.96% register free of charge , the lowest is CN¥67.40 0.96% register free of charge .
	A rating was issued by 7 analysts: 6 Analysts recommend Cansino Biologics Inc-h to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Cansino Biologics Inc-h stock has an average upside potential 2027 of 0.02% register free of charge . Most analysts recommend the Cansino Biologics Inc-h stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2029

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '25	2026 Estimates
Revenue Billion CN¥	1.07	1.46
	26.18%	36.72%
EBITDA Margin	10.62%	22.85%
	138.48%	115.14%
Net Margin	2.61%	9.07%
	105.83%	247.54%

2 Analysts have issued a sales forecast Cansino Biologics Inc-h 2026 . The average Cansino Biologics Inc-h sales estimate is

unlock

. This is

unlock

than the revenue of the last 12 months(TTM). The highest sales forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics:

2025	CN¥1.1b	26.18%
2026	CN¥1.5b 36.72% unlock
2027	CN¥1.8b 20.41% unlock
2028	CN¥2.6b 46.81% unlock
2029	CN¥2.7b 6.24% unlock

2 Cansino Biologics Inc-h Analysts have issued a net profit forecast 2026. The average Cansino Biologics Inc-h net profit estimate is

unlock

. This is

unlock

than the net profit for the last 12 months(TTM). The highest net profit forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future Net Margins:

2025	CN¥27.9m	107.36%
2026	CN¥132m 375.10% unlock
2027	CN¥197m 49.12% unlock
2028	CN¥681m 244.89% unlock
2029	CN¥828m 21.56% unlock

2025	2.61%	105.83%
2026	9.07% 247.54% unlock
2027	11.23% 23.81% unlock
2028	26.38% 134.91% unlock
2029	30.19% 14.44% unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2029

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '25	2026 Estimates
Earnings Per Share CN¥	0.11	0.58
	107.19%	427.27%
P/E		114.73
EV/Sales		6.38

Based on analysts' sales estimates for 2026, the Cansino Biologics Inc-h stock is valued at an EV/Sales of

unlock

and an P/S ratio of

unlock

This results in the following potential growth metrics and future valuations:

Current	8.31
2026	6.38 23.22% unlock
2027	5.30 16.95% unlock
2028	3.61 31.89% unlock
2029	3.40 5.87% unlock

Current
2026	7.01 23.22% unlock
2027	5.82 16.95% unlock
2028	3.97 31.89% unlock
2029	3.73 5.87% unlock

Cansino Biologics Inc-h...

Discover more stocks with a high price target

NIO ADR 102.31%

Alibaba Group Holding Ltd 75.49%

Infineon 69.69%

Rheinmetall 60.60%

Tencent Holdings Ltd. 60.42%

TUI 52.29%

Siemens Energy 47.46%

Adyen 47.42%

Adidas 46.48%

Uber Technologies 45.36%

BYD 41.55%

NVIDIA 39.51%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now